Efficacy and safety of aclidinium/formoterol versus monotherapies and aclidinium versus placebo in Chinese and other Asian patients with moderate-to-severe COPD: The AVANT Phase 3 study
- Resource Type
- Article
- Source
- In
Respiratory Medicine November 2023 218 - Subject
- Language
- ISSN
- 0954-6111